ArticleOncotarget2017

MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.

Lidia Maria Rebolho Batista Arantes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.